Cipher Pharmaceuticals Inc.
CPHRF
$7.50
-$0.35-4.46%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 95.51% | -9.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 95.51% | -9.60% | |||
| Cost of Revenue | 78.12% | 4.83% | |||
| Gross Profit | 100.10% | -12.76% | |||
| SG&A Expenses | 249.66% | -10.29% | |||
| Depreciation & Amortization | 559.25% | 1.04% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 213.08% | -3.45% | |||
| Operating Income | -27.77% | -15.25% | |||
| Income Before Tax | -87.04% | -15.26% | |||
| Income Tax Expenses | 108.96% | 75.45% | |||
| Earnings from Continuing Operations | -90.55% | -39.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -90.55% | -39.16% | |||
| EBIT | -27.77% | -15.25% | |||
| EBITDA | 31.73% | -13.85% | |||
| EPS Basic | -90.98% | -39.47% | |||
| Normalized Basic EPS | -34.90% | -6.21% | |||
| EPS Diluted | -91.67% | -40.00% | |||
| Normalized Diluted EPS | -34.97% | -6.32% | |||
| Average Basic Shares Outstanding | 4.39% | 0.49% | |||
| Average Diluted Shares Outstanding | 4.58% | 0.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
